48.20 0.00 (0.00%)
After hours: 4:48PM EDT
|Bid||48.36 x 1000|
|Ask||48.38 x 1000|
|Day's Range||47.76 - 49.06|
|52 Week Range||37.73 - 76.56|
|Beta (3Y Monthly)||1.50|
|PE Ratio (TTM)||7.82|
|Earnings Date||Aug 1, 2019|
|Forward Dividend & Yield||1.32 (2.72%)|
|1y Target Est||55.00|
Another win for the market on Thursday, with the S&P 500 ending the session up 0.23% to finish the session at just a hair below 3,000. The volume grew once again on the third-straight daily gain, though it is still below average.Source: Shutterstock CVS Health (NYSE:CVS) and UnitedHealth Group (NYSE:UNH) ranked among the session's biggest winners, up 4.7% and 5.5%, respectively, after President Trump decided to not enact new rules that would stymie rebates on pharmaceutical purchases. At the other end of the spectrum, Merck (NYSE:MRK) led the losers on Thursday, as the President's move worried some that it could end up being pharmaceutical companies that bore the brunt of any cost-control initiatives. Merck shares ended the day down by 4.5%. * 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond Headed into the final trading day of the week, though, it's HollyFrontier (NYSE:HFC), Activision Blizzard (NASDAQ:ATVI) and Vertex Pharmaceuticals (NASDAQ:VRTX) that merit the closest looks from traders. Here's why, and what to look for.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Vertex Pharmaceuticals (VRTX)Vertex Pharmaceuticals is still technically in a long-term uptrend, guided higher by a rising support line that extends all the way back to late-2017. Although it has ebbed and flowed along the way, it has made higher highs and higher lows for some time now.The flavor of the advance changed in a fundamental way this year, however, and although it has been more erratic than not, current and prospective owners may want to note that the repeated bearish swings are taking a cumulative toll on the broad uptrend. Click to Enlarge * Chief among the changes in the timbre of the major rally is the fact that for the first time in several quarters, VRTX has logged a streak of lower highs. They're plotted in yellow on both stock charts. * The long-term support line is marked with a dashed blue line on both charts. * It's easy to look past in the wide swings we've seen since the beginning of 2018, but the most recent round of weakness has pulled the purple 50-day moving average line below the white 200-day line for the first time since mid-2018 (although that instance proved to be a great entry point). HollyFrontier (HFC)Late last month, HollyFrontier shares were able to punch through a long-standing falling resistance line, and proceed to test their 100-day moving average line, marked in gray on both stock charts. That test ultimately failed, sending HFC lower again. Shares only needed to take a small step back before renewing a much-needed running start. The second effort made a big dent on Thursday. * 7 Marijuana Stocks With Critical Levels to Watch Click to Enlarge * The resistance line in question is marked in yellow on both stock charts. In retrospect, May's steep selloff served as the capitulation the chart needed. * Although it faltered the first time when attempting to push past the moving average line (highlighted), Thursday's second attempt worked nicely. * While the volume behind the runup since May's bottom is on reasonably healthy volume, the pace hasn't been healthy. HollyFrontier isn't yet stochastically overbought, but it's getting to that point fast. Activision Blizzard (ATVI)Finally, within nothing more than a quick glance, Activision Blizzard shares merely look stuck in a trading range. And, that may well be the case. A deeper look at some of the more subtle clues, however, suggests the bulls may be working on a bigger-picture recovery of last year's oversized pullback. The inflection point is within sight too, with a massive amount of room to run if and when the last hurdle area is cleared. Click to Enlarge * The subtle hints are not just the bullish crosses of most of the moving average lines on the daily chart. Since the end of last month, the 20-, 50- and 100-day moving average lines are acting as support. * The inflection point, or final potential resistance, is the 200-day moving average line at $51, plotted in white on both stock charts. In the meantime, there's horizontal resistance around $48.80. * The weekly chart puts the potential rebound in perspective. It also better identifies the fact that we've already seen a higher low.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about him at his website jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Buy for Less Than Book * 7 Marijuana Stocks With Critical Levels to Watch * The 10 Best Dividend Stocks to Buy for the Rest of 2019 and Beyond The post 3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals appeared first on InvestorPlace.
Phillips 66 is expected to post an EPS of $2.52 in the second quarter—10% lower than its adjusted EPS in the second quarter of 2018.
Let's look at what analysts expect for refining companies Marathon Petroleum (MPC), HollyFrontier (HFC), Valero Energy (VLO), and Phillips 66 (PSX) in the second quarter.
Let's review the forward valuations of refiners Phillips 66 (PSX), Marathon Petroleum (MPC), Valero Energy (VLO), and HollyFrontier (HFC).
The short interests (percentage of outstanding shares) in Marathon Petroleum (MPC), Valero Energy (VLO), Phillips 66 (PSX), and HollyFrontier (HFC) have put up mixed trends since April 1, 2019.
HollyFrontier (HFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Institutional ownership in Valero Energy (VLO), Marathon Petroleum (MPC), Phillips 66 (PSX), and HollyFrontier (HFC) stands above 70%. Let's take a closer look.
Refining stocks’ dividend yields have grown in the past year. In most cases, this growth has been led by falls in their stock prices and rises in their dividends.
Refining stocks put up mixed performances in the second quarter. While Marathon Petroleum (MPC), Phillips 66 (PSX), and HollyFrontier (HFC) stocks fell, Valero Energy (VLO) rose.
In the second quarter of 2019, Valero Energy (VLO) rose 0.9%, while Marathon Petroleum (MPC), Phillips 66 (PSX), and HollyFrontier (HFC) fell 6.6%, 1.7%, and 6.1%, respectively.
Analysts' ratings for HollyFrontier (HFC) show that three (or 18%) out of 17 have rated it as a “buy” in June. Another 11 analysts (or 65%) have rated HollyFrontier as a “hold.”
Let's rank six US refiners based on the number of "buy" ratings they've received from Wall Street analysts ahead of their second-quarter earnings results.
Wall Street analysts estimate HollyFrontier’s (HFC) earnings to fall 30% in 2019. Delek US Holdings (DK), Valero Energy (VLO), and Marathon Petroleum’s (MPC) EPS are expected to fall by 4%, 10%, and 21%, respectively, in the year. HollyFrontier has refining, midstream, and lubricant and specialty products business segments.
Wall Street analysts expect refining firms' earnings to fall in 2019. Delek US Holdings (DK) and Valero Energy’s (VLO) earnings are estimated to fall less than 10% in 2019. However, the EPS of Marathon Petroleum (MPC), HollyFrontier (HFC), and Phillips 66 (PSX) are expected to fall 20%–40% this year.
President Trump confirmed he cancelled the strike on Iran because the potential Iranian deaths won't be 'proportionate' to the unmanned U.S. drone that Iran shot down earlier this week. Heritage Foundation Vice President James Carafano joins Yahoo Finance's Seana Smith along with Kramer Capital Research CIO Hilary Kramer.